Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 763066
                    [Title] => Avastin disappoints against ovarian cancer
                    [Summary] => 
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer,  too.
                    [DatePublished] => 2011-12-30 01:07:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 749485
                    [Title] => FDA revokes approval of Avastin for breast cancer
                    [Summary] => 
The blockbuster drug Avastin should no longer be used in advanced breast cancer patients because there's no proof that it extends their lives and it presents dangerous side effects, the government declared Friday.
                    [DatePublished] => 2011-11-19 02:08:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 680468
                    [Title] => Cheaper eye drug proves as good as pricier one
                    [Summary] => 
A new study shows that a cheaper drug for a common eye disease is as  effective as a more expensive one approved for the condition.
                    [DatePublished] => 2011-04-29 03:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 531814
                    [Title] => Novel drug combo improves breast cancer survival
                    [Summary] => 
SAN ANTONIO (AP) — Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other medicines, doctors reported Frida
                    [DatePublished] => 2009-12-13 00:01:11
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 531829
                    [Title] => Novel drug combo ups breast cancer survival
                    [Summary] => 
Some women with very advanced breast cancer may have a new treatment option.
                    [DatePublished] => 2009-12-13 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Cebu News
                    [SectionUrl] => cebu-news
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 492400
                    [Title] => US clears Genentech drug for kidney cancer
                    [Summary] => 
WASHINGTON (AP) --­ Biotech drugmaker Genentech Inc. said Sunday that US regulators have approved its cancer treatment Avastin for a new use against a form of kidney cancer, marking the sixth approval for the blockbuster drug.
                    [DatePublished] => 2009-08-03 11:09:43
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 250979
                    [Title] => Signs to look for in a successful date
                    [Summary] => Ifeel so dejected. The man of my dreams finally asked me for a date and I thought we had such a good time. I think I did everything right, according to the rules of the game. I read up on all the things that interested him (I did research on him), I did not talk about me, me and me (even if I am quite accomplished and rich), I did not order the most expensive item on the menu and I did not drink more than one glass of wine, and I wore the latest fashion from Mango.
                    [DatePublished] => 2004-05-22 00:00:00
                    [ColumnID] => 135486
                    [Focus] => 0
                    [AuthorID] => 1739447
                    [AuthorName] => SAVOIR FAIRE By Mayenne Carmona
                    [SectionName] => Modern Living
                    [SectionUrl] => modern-living
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 239338
                    [Title] => New drugs for 2004
                    [Summary] => Some of the most outstanding stories in medicine in 2004 will involve new drugs to treat an assortment of ills, new uses for existing medications, and the possible availability of some drugs now sold only by prescription to over-the-counter status.


Here are the drugs that are expected to produce a significant impact on health care in 2004. 


• Cancer. A highly anticipated class of cancer drugs called anti-angiogenesis agents may finally become available. Anti-angiogenesis agents act by blocking the formation and growth of new blood vessels that feed tumors. 


                    [DatePublished] => 2004-02-17 00:00:00
                    [ColumnID] => 133436
                    [Focus] => 0
                    [AuthorID] => 1778504
                    [AuthorName] => Tyrone M. Reyes M.D.
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

AVASTIN

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 763066
                    [Title] => Avastin disappoints against ovarian cancer
                    [Summary] => 
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer,  too.
                    [DatePublished] => 2011-12-30 01:07:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 749485
                    [Title] => FDA revokes approval of Avastin for breast cancer
                    [Summary] => 
The blockbuster drug Avastin should no longer be used in advanced breast cancer patients because there's no proof that it extends their lives and it presents dangerous side effects, the government declared Friday.
                    [DatePublished] => 2011-11-19 02:08:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 680468
                    [Title] => Cheaper eye drug proves as good as pricier one
                    [Summary] => 
A new study shows that a cheaper drug for a common eye disease is as  effective as a more expensive one approved for the condition.
                    [DatePublished] => 2011-04-29 03:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 531814
                    [Title] => Novel drug combo improves breast cancer survival
                    [Summary] => 
SAN ANTONIO (AP) — Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other medicines, doctors reported Frida
                    [DatePublished] => 2009-12-13 00:01:11
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 531829
                    [Title] => Novel drug combo ups breast cancer survival
                    [Summary] => 
Some women with very advanced breast cancer may have a new treatment option.
                    [DatePublished] => 2009-12-13 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Cebu News
                    [SectionUrl] => cebu-news
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 492400
                    [Title] => US clears Genentech drug for kidney cancer
                    [Summary] => 
WASHINGTON (AP) --­ Biotech drugmaker Genentech Inc. said Sunday that US regulators have approved its cancer treatment Avastin for a new use against a form of kidney cancer, marking the sixth approval for the blockbuster drug.
                    [DatePublished] => 2009-08-03 11:09:43
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 250979
                    [Title] => Signs to look for in a successful date
                    [Summary] => Ifeel so dejected. The man of my dreams finally asked me for a date and I thought we had such a good time. I think I did everything right, according to the rules of the game. I read up on all the things that interested him (I did research on him), I did not talk about me, me and me (even if I am quite accomplished and rich), I did not order the most expensive item on the menu and I did not drink more than one glass of wine, and I wore the latest fashion from Mango.
                    [DatePublished] => 2004-05-22 00:00:00
                    [ColumnID] => 135486
                    [Focus] => 0
                    [AuthorID] => 1739447
                    [AuthorName] => SAVOIR FAIRE By Mayenne Carmona
                    [SectionName] => Modern Living
                    [SectionUrl] => modern-living
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 239338
                    [Title] => New drugs for 2004
                    [Summary] => Some of the most outstanding stories in medicine in 2004 will involve new drugs to treat an assortment of ills, new uses for existing medications, and the possible availability of some drugs now sold only by prescription to over-the-counter status.


Here are the drugs that are expected to produce a significant impact on health care in 2004. 


• Cancer. A highly anticipated class of cancer drugs called anti-angiogenesis agents may finally become available. Anti-angiogenesis agents act by blocking the formation and growth of new blood vessels that feed tumors. 


                    [DatePublished] => 2004-02-17 00:00:00
                    [ColumnID] => 133436
                    [Focus] => 0
                    [AuthorID] => 1778504
                    [AuthorName] => Tyrone M. Reyes M.D.
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

Avastin disappoints against ovarian cancer

December 30, 2011 - 1:07am

Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too.

FDA revokes approval of Avastin for breast cancer

November 19, 2011 - 2:08am

The blockbuster drug Avastin should no longer be used in advanced breast cancer patients because there's no proof that it extends their lives and it presents dangerous side effects, the government declared Frid...

Cheaper eye drug proves as good as pricier one

April 29, 2011 - 3:00am

A new study shows that a cheaper drug for a common eye disease is as effective as a more expensive one approved for the condition.

Novel drug combo improves breast cancer survival

December 13, 2009 - 12:01am

SAN ANTONIO (AP) — Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had...

Novel drug combo ups breast cancer survival

December 13, 2009 - 12:00am

Some women with very advanced breast cancer may have a new treatment option.

Cebu News

US clears Genentech drug for kidney cancer

August 3, 2009 - 11:09am

WASHINGTON (AP) --­ Biotech drugmaker Genentech Inc. said Sunday that US regulators have approved its cancer treatment Avastin for a new use against a form of kidney cancer, marking the sixth approval for the...

Signs to look for in a successful date

By SAVOIR FAIRE By Mayenne Carmona | May 22, 2004 - 12:00am

Ifeel so dejected. The man of my dreams finally asked me for a date and I thought we had such a good time. I think I did everything right, according to the rules of the game. I read up on all the things that interested...

Modern Living

New drugs for 2004

By Tyrone M. Reyes M.D. | February 17, 2004 - 12:00am

Some of the most outstanding stories in medicine in 2004 will involve new drugs to treat an assortment of ills, new uses for existing medications, and the possible availability of some drugs now sold only by prescription...

Health And Family

next